Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Wells Fargo Maintains Overweight on MetLife, Lowers Price Target to $83

Author: Benzinga Newsdesk | February 06, 2024 12:10pm
Wells Fargo analyst Elyse Greenspan maintains MetLife (NYSE:MET) with a Overweight and lowers the price target from $85 to $83.

Posted In: MET

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist